facebook pixel
Gondola Logo
X aka Twitter
@Novartis
BREAKING: Additional analysis from a Phase III trial of our investigational PI3K inhibitor for HR+/HER2- #metastaticBC presented at #SABCS18. Learn more at: t.co/mVPtXdDUVW #NovartisNews
Posted on Twitter at 12/6/2018, 3:59:02 PM

 25

 11

    Suggested Credits
    Tags, Events, and Projects